REGENXBIO (RGNX) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 6.00 | 1.10 | 0.78 | -1.16 | -5.80 | -1.40 | ||
| Changes by years, y/y, % | -145% | -82% | -30% | -249% | +400% | -15.3% | |||
REGENXBIO. EV/EBITDA
REGENXBIO. EV/EBITDA, changes, %
REGENXBIO (RGNX) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -1.46 | -1.36 | -4.11 | -5.82 | -1.57 | -1.40 | |
| Changes by years, y/y, % | -306% | -327% | +147% | +380% | +7% | |||
| Changes by quarters, q/q, % | +21% | -7% | +201% | +42% | -73% | |||